Skip to main content

Blog

Strong Evidence of Use

October 12, 2022

Strong Evidence of Use (EoU) is a critical component in the successful monetization of a patent portfolio, buyers and licensees frequently base their decision on the presence of strong EoU.

Quickview

Noember 29, 2022

Pelent’s Portfolio Analyzer provides an overall portfolio snapshot including Patent Rating metrics and a ‘floorplan’ visualization which allows users to hone into technology areas with the highest concentration of valuable patents.

Diamonds in the Rough

March 3, 2022

While companies grapple with the chip shortage of 2022 there is no shortage of valuable patents at chip-designer Arm Limited. “Diamond” high value patents hold the potential to generate revenue through licensing or may be leveraged defensively if acquired by a practicing entity.

Patently Clear

December 1, 2022

Pelent’s Portfolio checkup gives you crystal clear results about your patents almost immediately. Case in point: Proterra (NASDAQ: PTRA), which appears to be firing on all cylinders – or should we say all battery packs.

Value versus Quality

january 24, 2023

The terms patent value and patent quality are used interchangeably and are often confused and misunderstood. While one cannot completely divorce quality and value, it is important to understand the distinction.

O Canada

February 25,2023

Just how well are Canadian companies faring filing new patents? We ran an analysis of US granted patents for Canadian companies in the first half of 2022. The analysis sampled 530 granted patents from 263 companies (mostly SME’s) and university organizations.

Canadian Made

July 1, 2023
Just how well are Canadian companies faring filing new patents in 2023? We ran an analysis for 1,574 US patents granted to Canadians for the first half of 2023. The analysis includes 857 assignees, Blackberry Ltd. ranks the top company with 72 granted US patents.

Celebrating a Milestone

August 15, 2023

We are pleased to announce that @Pelent is celebrating a remarkable milestone – our 7th anniversary! The journey has been incredible, marked by innovation and most importantly our client support.

You can’t control what you can’t measure

November 22, 2023
Andrew Grove the former CEO of Intel was known for his emphasis on data-driven decision-making to guide management practices. The quote “You can’t control what you can’t measure” is often attributed to Peter Drucker, a renowned management consultant, educator, and author.

Strategic Alliance

December 29, 2023
We are excited to announce a significant development that will further enhance our commitment to delivering unparalleled professional patent services. Today, Pelent Patent Analytics is pleased to unveil a strategic alliance with SWOT Law, a leading expert in IP strategy.

Patent Impairment

MAY 25, 2024

Accounting for patents involves recognizing their cost, amortizing over their useful life, testing for impairment, and optionally revaluing them. A portfolio checkup allows accounting teams and portfolio managers to hone into low value assets and declare impaired patents as necessary.

OpenAI’s patent pledge less than it seems

october 12, 2024

In what some are calling a virtue-signalling stunt, OpenAI recently pledged to use their patents for defensive purposes only, as long as parties don’t assert claims against them or engage in harmful activities.

AI-Powered NLP

Pelent's AI system simplifies the process to assess a patent's commercial value and enforceability. It helps evaluate the patent's ability to prevent infringement, compare and value patent portfolios, and identify high-potential licensing candidates. Assessments are cost-effective, accurate and deliver actionable results swiftly.

Clients work smarter and faster, achieving data-driven and accurate results. Whether you need a patent assessment or want to determine the likelihood of successfully licensing or selling a portfolio, we have you covered.

Access a Free Trial

There is no other system like it